Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470164) titled 'Botulinum Toxin A vs Strabismus Surgery for Esotropia' on March 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Jaeb Center for Health Research
Condition:
Esotropia
Intervention:
Drug: Botulinum toxin A
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: January 2027
Target Sample Size: 244
To know more, visit https://clinicaltrials.gov/study/NCT07470164
Disclaimer: Curated by HT Syndication....